Announcements
- 2023.11.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
- 2023.10.31 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS TRAVEL II RESULTS RELEASED AT THE 2023 TCT IN THE U.S.
- 2023.10.30 VOLUNTARY ANNOUNCEMENT KEN-VALVE REGISTRATION APPLICATION ENTERS NMPA PRIORITY APPROVAL PROCESS
- 2023.10.20 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SUCCESSFULLY COMPLETES A SERIES OF FEE-FOR-SERVICE COMPASSIONATE USE TREATMENTS IN THE ASIA-PACIFIC REGION
- 2023.10.19 VOLUNTARY ANNOUNCEMENT RELEASE OF THE RESULTS OF THE MULTICENTER CLINICAL TRIAL OF LUX-VALVE PLUS AT THE 2023 TCT IN THE U.S.
- 2023.10.11 VOLUNTARY ANNOUNCEMENT REGISTRATION APPLICATION FOR KEN-VALVE ACCEPTED BY THE NMPA
- 2023.10.10 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SELECTED FOR THE EXPERT PANEL SCIENTIFIC ADVICE PILOT
- 2023.10.06 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
- 2023.09.18 2023 Interim Report
- 2023.09.18 VOLUNTARY ANNOUNCEMENT ENROLLED IN FDA TOTAL PRODUCT LIFE CYCLE ADVISORY PROGRAM (TAP) PILOT
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
